Please assess the completion status of the following clinical trial:

Trial Title: Menopausal Sleep Fragmentation and Body Fat Gain

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy premenopausal women 18-45 years old~* Regular sleep schedule~* Limited alcohol and caffeine intake~* Regular monthly menstrual cycles~* No lifetime history of hot flashes~* Willingness to use approved methods of contraception during study~* Not obese~* Good general health~Exclusion Criteria:~* Contraindication, hypersensitivity or previous adverse reaction to gonadotropin releasing hormone agonists~* Pregnancy~* Breastfeeding~* Tobacco use~* Contraindicated systemic hormone medications or centrally active medications~* Shift workers or recent/expected time zone travel~* Obstructive sleep apnea~* Insomnia symptoms~* Diagnosis of osteoporosis or osteopenia~* Hypothalamic-pituitary-adrenal axis disorders~* Diabetes~* Gastric bypass, metabolic disorders, or other related conditions~* Abnormalities on screening laboratory tests~* Substantial hearing impairment~* Cardiovascular illness~* Neurological illness~* Recent psychiatric illness or substance-use disorder

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Study arm (Type: EXPERIMENTAL): Participants completed 2 nights of unfragmented sleep followed by 3 nights of experimentally-fragmented sleep during high estradiol (E2) phase of their menstrual cycle (Sleep Block 1). A subset of participants repeated these procedures in an experimentally-induced low-E2 state (Sleep Block 2).

Based on this trial design, predict the completion outcome and termination type (if applicable).